Modifi Bio

About:

Modifi Biosciences is a direct DNA modification developing novel cancer therapeutics.

Website: https://modifibio.com

Top Investors: Connecticut Innovations, National Cancer Institute, Pathway Bioventures, Yale Ventures, Ironwood Capital

Description:

Modifi Biosciences is a direct DNA modification developing novel cancer therapeutics. The company's strategy for combating cancer centers around modifying tumor DNA in a way that renders cancer cells irreparable while preserving the integrity of healthy cells. This unique approach empowers researchers to disrupt traditional oncology drug development methods.

Total Funding Amount:

$13.1M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

New Haven, Connecticut, United States

Founded Date:

2021-01-01

Contact Email:

info(AT)modifibio.com

Founders:

Ranjit S. Bindra

Number of Employees:

11-50

Last Funding Date:

2023-10-16

IPO Status:

Private

Industries:

© 2025 bioDAO.ai